Generic Name: Ticagrelor Tablets
[Ingredients]
ppearance]
[Indications]
In patients with ACS, this product has been studied in combination with aspirin. It was found that a maintenance dose of aspirin greater than 100 mg would reduce the clinical efficacy of ticagrelor in reducing composite endpoint events. Therefore, the maintenance dose of aspirin should not exceed 100 mg per day.
[Package]
[Executive Standard] YBH01502022
![1H-Pyrrolo[2,3-c]PYRIDINE-3-acetic Acid, 4-METHOXY-7-(3-Methyl-1H-1,2,4-TRIAZOL-1-yl)--oxo-, Methyl](/uploads20/image/exportchempharm/simg_GC11354850_CA11354926/1H-Pyrrolo-2-3-c-PYRIDINE-3-acetic-Acid--4-METHOXY-7--3-Methyl-1H-1-2-4-TRIAZOL-1-yl---oxo---Methyl.jpg)
